HB 565 - Requires Insurance Plans to Cover Biomarker Testing for Cancer - Mississippi Key Vote

Stage Details

Title: Requires Insurance Plans to Cover Biomarker Testing for Cancer

See How Your Politicians Voted

Title: Requires Insurance Plans to Cover Biomarker Testing for Cancer

Vote Smart's Synopsis:

Vote to pass a bill that requires insurance plans to cover biomarker testing for cancer in Mississippi.

Highlights:

  • Requires all health benefit plans to provide coverage for biomarker testing for the purpose of diagnosis, treatment, or monitoring of an enrollee’s disease (Sec. 3).

  • Requires all health benefit plans to ensure that coverage is provided in a manner that limits disruptions in care (Sec. 3).

  • Requires health benefit plans and insurance issuers to update and make available medical policies and guidelines within 60 days after enactment (Sec. 3)

  • Requires health benefit plans and insurance issuers to make any changes to coverage publicly available 30 days before the effective date of this act (Sec. 3).

  • Requires health benefit plan and insurance issuers to provide written justification for any coverage denials to the requesting party (Sec. 3).

  • Requires the update of fee schedules for medicare services to occur within 60 days of the effective date of this act (Sec. 4).

  • Specifies that this Act is effective on July 1st, 2026 (Sec. 6).

See How Your Politicians Voted

Title: Requires Insurance Plans to Cover Biomarker Testing for Cancer

Vote Smart's Synopsis:

Vote to pass a bill that requires insurance plans to cover biomarker testing for cancer in Mississippi.

Highlights:

  • Requires all health benefit plans to provide coverage for biomarker testing for the purpose of diagnosis, treatment, or monitoring of an enrollee’s disease (Sec. 3).

  • Requires all health benefit plans to ensure that coverage is provided in a manner that limits disruptions in care (Sec. 3).

  • Requires health benefit plans and insurance issuers to update and make available medical policies and guidelines within 60 days after enactment (Sec. 3)

  • Requires health benefit plans and insurance issuers to make any changes to coverage publicly available 30 days before the effective date of this act (Sec. 3).

  • Requires health benefit plan and insurance issuers to provide written justification for any coverage denials to the requesting party (Sec. 3).

  • Requires the update of fee schedules for medicare services to occur within 60 days of the effective date of this act (Sec. 4).

  • Specifies that this Act is effective on July 1st, 2026 (Sec. 6).

Title: Requires Insurance Plans to Cover Biomarker Testing for Cancer

arrow_upward